Medytox Competitors and Similar CompaniesClear all
Medytox's competitors and similar companies include Ipsen, CSL Behring and Biogen.
 Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. | ||||
Founding Date | Founding Date 2000 | Founding Date 1929 | Founding Date 1904 | Founding Date 1978 |
Type | Type Public | Type Public | Type Subsidiary | Type Public |
Tags | ||||
Locations | Locations KR HQ Minato City, JP Minato City, JP | Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more |
Employees | Employees 7213% increase | Employees 5,358 | Employees 7,5692% decrease | Employees 7,605 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 10.2 b | Valuation ($) N/A | Valuation ($) 26.7 b |
Financial | ||||
Revenue (est.) | Revenue (est.) ₩247.3b (FY, 2025) | Revenue (est.) €3.7b (FY, 2025) | Revenue (est.) $7.9b (FY, 2020) | Revenue (est.) $9.9b (FY, 2025) |
Cost of goods | Cost of goods ₩87.9b (FY, 2025) | Cost of goods €659.1m (FY, 2025) | Cost of goods N/A | Cost of goods $2.4b (FY, 2025) |
Gross profit | Gross profit ₩160.4b (FY, 2025) | Gross profit €3.3b (FY, 2025) | Gross profit $4.5b (FY, 2020) | Gross profit $7.5b (FY, 2025) |
Net income | Net income ₩15.7b (FY, 2025) | Net income €445.1m (FY, 2025) | Net income N/A | Net income $1.3b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Biogen
HQ
Cambridge, US
Employees
7,605
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View company